InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: DaveAu post# 1294

Friday, 11/08/2019 6:35:46 PM

Friday, November 08, 2019 6:35:46 PM

Post# of 8393
I think this thesis has been hashed few times. And I absolutely agree. Happy patients are big favor and providers consider them recurring revenues and won’t take risk alienating them. However label is important to really cement this differentiation. My concern is with only 50% of trial patients showing 24w duration, is it enough to convince the FDA ?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News